Insights from the Trenches with Genomics Startup Founders   In the first Genome Startup Day event of 2021, we highlighted one of the most critical decisions facing early-stage founders: whether or not to enter an accelerator or incubator. Three genomics startup founders from across the US shared how their unique experiences helped shape their company’s... Read more »

  Insights for biotech founders from a leading voice in genomics commercialization   What’s in a fancy startup C-suite title? The answer from luminaries is: “nothing if the startup fails.” In the first Genome Startup Day of 2021, Phase Genomics’ Founder and CEO Ivan Liachko, PhD, sat down with Mostafa Ronaghi, PhD, Senior VP for... Read more »

  The impact of fungal rust pathogens is measured in tens of thousands of acres of lost crops annually and an increasingly vulnerable supply chain. An outbreak of oat crown rust devastated yields in South Dakota and Minnesota, wiping out as much as 50% of the crop in 2014 alone.     Current surveillance rust collections... Read more »

  Greetings from, mercifully, the beginning days of 2021. As the world reels from Covid-19, all of our personal and professional lives have all been turned upside down. Despite this challenging environment, Phase Genomics has celebrated some big wins in 2020, amidst a tumultuous year. This year’s successes include releasing a dedicated Proximo Hi-C Kit... Read more »

In the last few years, Hi-C technology has grown in popularity within the epigenetics community. The chief application this proprietary method is to measure the three-dimensional architecture of genomes to better understand complex nuclear dynamics. Being a leader in this space, we at Phase Genomics seek to maximize the commercial footprint of our technology. As interest in this... Read more »

  By Ivan Liachko, Ph.D – Founder & CEO, Phase Genomics   As we enter the era of personalized medicine, novel genomic technologies are enabling a much deeper understanding of the biology of individual people. Such knowledge improves our ability to detect and diagnose diseases, offering personalized treatments that leverage each person’s unique genetic makeup... Read more »

  This month Phase Genomics is celebrating #FungusFebruary by highlighting some of the unique capabilities of our Hi-C technology to solve age-old mysteries in the world of fungal genetics and deliver new potential for researchers to understand fungi, all while helping solve global crop crises and develop new groundbreaking pharmaceuticals. While we wield the power... Read more »

  From scaling up the ProxiMeta Platform to publishing numerous Hi-C papers, Phase Genomics has had a year filled with new products, new discoveries, and new applications. Proximity ligation technology is continuing to fuel genomic and metagenomic research. Here is a brief recap of newsworthy items from 2019.     Metagenomics Publications MAY 30, 2019... Read more »

Nanopore and Hi-C produce a new fully-phased, chromosome-scale genome for the red raspberry. On October 22, scientists at KeyGene revealed the first fully-phased, chromosome-scale reference genome for the red raspberry, sequenced with Oxford Nanopore long-read technology and scaffolded and phased into full chromosomes using Phase Genomics’ Proximo™ Hi-C method.   Assembling complex plant genomes used to... Read more »

Congratulations to Dr. Ben Tully on winning this year’s Project ProxiMeta: 2019 Metagenomics Award! Read more about his project, 4. The Complete Hydrothermal Microbial Metal Metabolism This summer, researchers from across the U.S. sent in short proposals for a chance to win a full-service ProxiMeta™ microbiome workup for a sample of their choice. ProxiMeta combines shotgun metagenomics with in... Read more »